The Prostate Health Index (PHI) Density: Are There Advantages Over PHI or Over the Prostate-Specific Antigen Density?

Background and aims: Overdiagnosis of prostate cancer (PCa) should be minimized. We wanted to evaluate the diagnostic performance of the prostate health index density (PHID) and compare it with that of the prostate health index (PHI) alone and of the prostate-specific antigen density (PSAD). Materia...

Full description

Bibliographic Details
Main Author: Garrido, M (author)
Other Authors: Ribeiro, R (author), Campos Pinheiro, L (author), Holdenrieder, S (author), Guimarães, J (author)
Format: article
Language:eng
Published: 2022
Subjects:
CHLC PAT CLIN
HSJ URO
Humans
Male
Area Under Curve
Biopsy
Prostate-Specific Antigen*
Prostatic Neoplasms* / diagnosis
Online Access:http://hdl.handle.net/10400.17/4207
Country:Portugal
Oai:oai:repositorio.chlc.min-saude.pt:10400.17/4207

Internet

http://hdl.handle.net/10400.17/4207

Similar Items